Obstetric Anesthesia Digest · 2019 · 11 citations · 0 references
MedicineMaternal HealthObstetricsMaternal MortalityMaternal-fetal MedicineNeonatologyAntenatal AssessmentAntenatal Risk AssessmentEclampsiaHigh-risk Pregnancy ManagementNeonatal Intensive CarePregnancyEarly Detection Of PreeclampsiaHealth Care Cost SavingsHigh-risk Obstetric PatientsNeonatal Intensive Care Unit AdmissionObstetric Risk AssessmentPreeclampsia Risk AssessmentPreeclampsia Risk ReductionPreeclampsia Risk Screening
( Am J Obstet Gynecol . 2018;218:612.e1–e6) Preeclampsia is a major cause of maternal and perinatal death and other adverse outcomes for mothers and babies, and has important health care cost implications. Previous studies have found a reduction of the risk of preeclampsia with the use of aspirin. This study aimed to examine the effect of aspirin on the length of stay in the neonatal intensive care unit (NICU), as well as evaluate the impact of screening for preeclampsia and aspirin treatment for high-risk patients on health care costs.